Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …

Pregnancy and Family Planning in Multiple Sclerosis : CONTINUUM: Lifelong Learning in
Neurology Account Register Activate Subscription Help Subscribe American Academy of …

Objective: The objective of this study was to develop evidence-based recommendations on
pregnancy management for persons with multiple sclerosis (MS). Background: MS typically …

Thyroid dysfunction (TD) frequently occurs as an autoimmune complication of immune
reconstitution therapy (IRT), especially in individuals with multiple sclerosis treated with …

The global incidence of multiple sclerosis (MS) appears to be increasing. Although it may
not be associated with a high mortality rate, this disease has a high morbidity rate which …

Pregnancy and multiple sclerosis: an update : Current Opinion in Obstetrics and Gynecology
Pregnancy and multiple sclerosis: an update : Current Opinion in Obstetrics and Gynecology …

Alemtuzumab (Lemtrada®) is an anti-CD52 monoclonal antibody approved in the EU for the
treatment of highly active relapsing-remitting multiple sclerosis (RRMS). In phase 3 trials in …

Multiple sclerosis (MS) is an autoimmune-mediated degenerative disease of the central
nervous system, characterized by inflammatory demyelination. It is primarily found in women …

Multiple sclerosis (MS) is an autoimmune disease characterized by a robust inflammatory
response against myelin sheath antigens, which causes astrocyte and microglial activation …

Autoimmune thyroid disease (AITD) is the most common adverse effect in alemtuzumab
(ALZ) treated relapsing–remitting (RR) multiple sclerosis (MS) patients. The objective of this …